Lee Junho, Oh Shin Ju, Ha Eunji, Shin Ga Young, Kim Hyo Jong, Kim Kwangwoo, Lee Chang Kyun
Department of Biology, Kyung Hee University, Seoul, Republic of Korea.
Department of Biomedical and Pharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea.
NPJ Genom Med. 2024 Oct 29;9(1):52. doi: 10.1038/s41525-024-00440-w.
The high prevalence of comorbid mental disorders (CMDs) in patients with inflammatory bowel disease (IBD) is well-documented. This study delves into the intricate CMD-IBD relationship through comprehensive analyses using human variants, gut microbiome, and anxiety/depression estimates from a cohort of 507 IBD patients and 75 controls. Notably, patients with IBD, especially those with CMD, exhibited lower diversity than controls. We identified 106 differentially abundant taxa (DATs) in IBD patients compared to controls and 21 DATs distinguishing CMD-affected from CMD-free IBD patients. Microbial IBD-risk scores, reflecting an individual's microbial burden for IBD, revealed a significant enrichment of IBD-risk signatures in CMD-affected patients compared to CMD-free patients. Additionally, there was an IBD-risk variant potentially regulating the abundance of an IBD/CMD-associated DAT, suggesting an interplay between IBD-risk variants and dysbiosis in CMD. Our investigation underscores the pivotal role of IBD-associated gut dysbiosis in predisposing IBD patients to CMD, partially through genetic variant-mediated mechanisms.
炎症性肠病(IBD)患者中合并精神障碍(CMD)的高患病率已有充分记录。本研究通过对507名IBD患者和75名对照组成的队列进行人类变异、肠道微生物群以及焦虑/抑郁评估的综合分析,深入探究CMD与IBD之间的复杂关系。值得注意的是,IBD患者,尤其是患有CMD的患者,其多样性低于对照组。与对照组相比,我们在IBD患者中鉴定出106个差异丰富的分类群(DAT),以及21个区分受CMD影响和未受CMD影响的IBD患者的DAT。反映个体IBD微生物负担的微生物IBD风险评分显示,与未患CMD的患者相比,受CMD影响的患者中IBD风险特征显著富集。此外,存在一个IBD风险变异体可能调节与IBD/CMD相关的DAT的丰度,这表明IBD风险变异体与CMD中的生态失调之间存在相互作用。我们的研究强调了IBD相关肠道生态失调在使IBD患者易患CMD方面的关键作用,部分是通过基因变异介导的机制。